LISINOPRIL

Product NDC
71335-0536
11-digit product format
713350536
Labeler code
71335
Product ID
71335-0536_eced30d2-db36-4ad3-a725-5b0cfb8726ad
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA076164
Marketing category
ANDA
Marketing start
2011-11-01
Substance
LISINOPRIL
Active strength
10 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
LISINOPRIL
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LISINOPRIL10 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiE7199S1YWR
Rxcui314076

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71335-0536-07133505360010 TABLET in 1 BOTTLE (71335-0536-0) 10 tablet2024-10-080000-00-00NoNoCurrent
71335-0536-17133505360130 TABLET in 1 BOTTLE (71335-0536-1) 30 tablet2018-03-210000-00-00NoNoCurrent
71335-0536-271335053602100 TABLET in 1 BOTTLE (71335-0536-2) 100 tablet2019-01-280000-00-00NoNoCurrent
71335-0536-37133505360360 TABLET in 1 BOTTLE (71335-0536-3) 60 tablet2018-08-200000-00-00NoNoCurrent
71335-0536-47133505360490 TABLET in 1 BOTTLE (71335-0536-4) 90 tablet2018-03-050000-00-00NoNoCurrent
71335-0536-57133505360520 TABLET in 1 BOTTLE (71335-0536-5) 20 tablet2018-06-260000-00-00NoNoCurrent
71335-0536-671335053606120 TABLET in 1 BOTTLE (71335-0536-6) 120 tablet2019-11-200000-00-00NoNoCurrent
71335-0536-7713350536077 TABLET in 1 BOTTLE (71335-0536-7) 7 tablet2019-03-210000-00-00NoNoCurrent
71335-0536-87133505360815 TABLET in 1 BOTTLE (71335-0536-8) 15 tablet2018-04-240000-00-00NoNoCurrent
71335-0536-9713350536092 TABLET in 1 BOTTLE (71335-0536-9) 2 tablet2022-01-190000-00-00NoNoCurrent